Literature DB >> 33718387

Circular RNA circ_0057558 Controls Prostate Cancer Cell Proliferation Through Regulating miR-206/USP33/c-Myc Axis.

Tao Ding1, Yanjun Zhu2, Huimin Jin3, Ping Zhang3, Jianming Guo2, Jianghua Zheng3.   

Abstract

We previously reported the elevated expression of circ_0057558 in prostate cancer tissues and cell lines. Here, we aimed to determine the biological function of circ_0057558 in prostate cancer. In the current study, circ_0057558 knockdown in prostate cancer cells significantly repressed cell proliferation and colony formation, but promoted cell arrest and enhanced the sensitivity to docetaxel. Bioinformatics analysis prediction and RNA-pull down assay identified miR-206 as the potential binding miRNA of circ_0057558. A negative correlation was observed between the expression of miR-206 and circ_0057558 in prostate cancer tissues. miR-206 mimics rescued the function of circ_0057558 overexpression on prostate cancer cells. Further, the bioinformatics analysis and luciferase assay suggested that miR-206 may target ubiquitin-specific peptidase 33 (USP33). USP33 mRNA expression has negative correlation with miR-206 expression and positive correlation with circ_0057558 expression in prostate cancer tissues. USP33 overexpression partially blocked the effects of miR-206 mimics on prostate cell proliferation. USP33 could bind and deubiquitinate c-Myc. Increased c-Myc protein by circ_0057558 overexpression was partially reversed by miR-206 mimics. The proliferation inhibition activity of MYC inhibitor 361 (MYCi361) was more prominent in primary prostate cancer cells and patient-derived xenograft (PDX) model with higher level of circ_0057558. Collectively, circ_0057558 gives an impetus to cell proliferation and cell cycle control in prostate cancer cell lines by sponging miR-206 and positively regulating the transcription of the miR-206 target gene USP33.
Copyright © 2021 Ding, Zhu, Jin, Zhang, Guo and Zheng.

Entities:  

Keywords:  circular RNA; deubiquitination; proliferation; prostate cancer; sponge

Year:  2021        PMID: 33718387      PMCID: PMC7952531          DOI: 10.3389/fcell.2021.644397

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  33 in total

1.  Circular RNA Expression Profiling Identifies Prostate Cancer- Specific circRNAs in Prostate Cancer.

Authors:  Qianlin Xia; Tao Ding; Guihong Zhang; Zehuan Li; Ling Zeng; Yanjun Zhu; Jianming Guo; Jun Hou; Tongyu Zhu; Jianghua Zheng; Jin Wang
Journal:  Cell Physiol Biochem       Date:  2018-11-05

Review 2.  Circular RNA: A new star of noncoding RNAs.

Authors:  Shibin Qu; Xisheng Yang; Xiaolei Li; Jianlin Wang; Yuan Gao; Runze Shang; Wei Sun; Kefeng Dou; Haimin Li
Journal:  Cancer Lett       Date:  2015-06-05       Impact factor: 8.679

3.  MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.

Authors:  Chunxiu Dai; Yongyong Xie; Xiaoping Zhuang; Zhengzhong Yuan
Journal:  Biomed Pharmacother       Date:  2018-05-29       Impact factor: 6.529

4.  MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11.

Authors:  Yao Wang; Haitao Xu; Lihui Si; Qiuju Li; Xiujie Zhu; Tong Yu; Xiaokun Gang
Journal:  Prostate       Date:  2018-03-14       Impact factor: 4.104

5.  USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.

Authors:  Zhaohui Huang; Pushuai Wen; Ruirui Kong; Haipeng Cheng; Binbin Zhang; Cao Quan; Zehua Bian; Mengmeng Chen; Zhenfeng Zhang; Xiaoping Chen; Xiang Du; Jianghong Liu; Li Zhu; Kazuo Fushimi; Dong Hua; Jane Y Wu
Journal:  Int J Cancer       Date:  2014-09-29       Impact factor: 7.396

6.  Modelling Myc inhibition as a cancer therapy.

Authors:  Laura Soucek; Jonathan Whitfield; Carla P Martins; Andrew J Finch; Daniel J Murphy; Nicole M Sodir; Anthony N Karnezis; Lamorna Brown Swigart; Sergio Nasi; Gerard I Evan
Journal:  Nature       Date:  2008-08-17       Impact factor: 49.962

7.  USP33, a new player in lung cancer, mediates Slit-Robo signaling.

Authors:  Pushuai Wen; Ruirui Kong; Jianghong Liu; Li Zhu; Xiaoping Chen; Xiaofei Li; Yongzhan Nie; Kaichun Wu; Jane Y Wu
Journal:  Protein Cell       Date:  2014-07-02       Impact factor: 14.870

8.  Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signaling.

Authors:  Hongda Liu; Qun Zhang; Kangshuai Li; Zheng Gong; Zhaochen Liu; Yunfei Xu; Mary Hannah Swaney; Kunhong Xiao; Yuxin Chen
Journal:  Oncotarget       Date:  2016-12-06

9.  Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo.

Authors:  Samireh Jorfi; Ephraim A Ansa-Addo; Sharad Kholia; Dan Stratton; Shaunelle Valley; Sigrun Lange; Jameel Inal
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

10.  Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation.

Authors:  Wenjia Xia; Mantang Qiu; Rui Chen; Siwei Wang; Xuechun Leng; Jie Wang; Youtao Xu; Jingwen Hu; Gaochao Dong; Prof Lin Xu; Rong Yin
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

View more
  4 in total

Review 1.  Circular RNAs and Drug Resistance in Genitourinary Cancers: A Literature Review.

Authors:  Gongwei Long; Siquan Ma; Runlin Shi; Yi Sun; Zhiquan Hu; Ke Chen
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

2.  circITGA7 Acts as a miR-370-3p Sponge to Suppress the Proliferation of Prostate Cancer.

Authors:  Gang Luo; Guohao Li; Zhihua Wan; Yuanjie Zhang; Dong Liu; Yonglian Guo
Journal:  J Oncol       Date:  2021-12-31       Impact factor: 4.375

3.  LMX1B Activated Circular RNA GFRA1 Modulates the Tumorigenic Properties and Immune Escape of Prostate Cancer.

Authors:  Min Meng; Yi-Chen Wu
Journal:  J Immunol Res       Date:  2022-07-04       Impact factor: 4.493

4.  [MicroRNA-424 inhibits autophagy and proliferation of hepatocellular carcinoma cells by targeting ATG14].

Authors:  Z Zhao; W Huang; J He; C Feng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.